Administration, TopicalAromatase InhibitorsArthralgia
Dr. Rebecca L. Glaser, MD
NPI1184816290
- Part D claims, 2024
- 186
- Publications
- 13
- Hospital affiliations
- 1
- Industry payments
- $16
- State license
- 1
- Practice address
- 405 Grand Avenue, Dayton, OH 45405
- Practice phone
- Call (937) 723-3410
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Glaser's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Rebecca L. Glaser is a surgical oncologist in Dayton, Ohio
Dr. Glaser practices at Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare.
Dr. Glaser's NPI, 1184816290, was assigned on August 13, 2007. Dr. Glaser holds Ohio license 35051389.
NPI and contact details
- NPI
- 1184816290NPI Registry (opens in a new tab)
- NPI enumeration date
- August 13, 2007
- NPI status
- Active
- Practice phone
- (937) 723-3410
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Rebecca L. Glaser practices at Kettering Health Dayton in Dayton, Ohio
Dr. Glaser's primary practice is Kettering Health Dayton, at 405 Grand Avenue, Dayton, OH 45405 in Montgomery County. The practice phone is (937) 723-3410.
- Kettering Health Dayton405 Grand Avenue, Dayton, OH 45405 · Montgomery CountyPhone(937) 723-3410
Source: Dmand AI Affiliation Data
Dr. Rebecca L. Glaser is affiliated with 2 sites of care
Dr. Glaser's primary practice is Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare. Dmand AI also links Dr. Glaser to 1 physician office, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Rebecca L. Glaser's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Glaser practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Kettering Health Dayton | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Glaser practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Kettering Adventist Healthcare and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Rebecca L. Glaser is one of 72 surgical oncologists in Ohio
Surgical oncology is Dr. Glaser's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Glaser is licensed in Ohio.
Specialties and state licenses
- Surgical oncology, OhioPrimary
Surgical oncologists near Dr. Glaser
Counts of surgical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
72surgical oncologists in Ohio
5surgical oncologists in Dayton
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Rebecca L. Glaser's patients have a median age of 61
Across all payers, Dmand AI patient panel data puts Dr. Glaser's median patient age at 61, with 58% women.
Dr. Glaser's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 61
Patient panel by sex, all payers
- Women58%
- Men42%
Source: Dmand AI Patient Panel Data
Dr. Rebecca L. Glaser wrote 186 Medicare Part D claims in 2024
In 2024, Dr. Glaser wrote 186 Medicare Part D claims for 79 patients. 89% of them were for generic drugs. CMS names the drug for 105 of them, across 4 drugs with 11 or more claims each, at $1,577 in total drug cost. In 2023, CMS named 158 claims across 5 drugs.
Part D claims, 2024186
Drugs named by CMS4
Total drug cost$1,577
Part D patients79
Dr. Glaser's Part D claims by kind of drug, 2024
- Generic166 claims89%
- Brand-name and other20 claims11%
Dr. Glaser's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Glaser's Part D claims, 2024
- Antibiotics18%33 of 186 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1582024: 10534%
Drugs named by CMS: 4 in 2024, 5 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find surgical oncologists like Dr. Glaser by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Rebecca L. Glaser has 13 publications on record
Dmand AI links 13 papers to Dr. Glaser, published from 2008 to 2020. 2012 was the busiest year, with 3. The most frequent topics are Testosterone, Breast Neoplasms and Anastrozole. Dr. Glaser has published most often in Maturitas. Dr. Glaser's most frequent co-authors are Elizabeth J. Cathcart-Rake, MD, Richard L. Deming, MD and Armando E. Giuliano, FACS, MD.
Papers13
Years published2008 to 2020
Dr. Glaser's papers by year, 2008 to 2020
Topics Dr. Glaser writes about most
- Testosterone
- Breast Neoplasms
- Anastrozole
- Androgens
- Drug Implants
- Hormone Replacement Therapy
- Triazoles
- Aromatase Inhibitors
Dr. Glaser's most frequent co-authors
- Elizabeth J. Cathcart-Rake, MD1 shared paper
- Richard L. Deming, MD1 shared paper
- Armando E. Giuliano, FACS, MD1 shared paper
Recent publications by Dr. Glaser
AnastrozoleBreast NeoplasmsDrug Implants
Maturitas
Breast NeoplasmsComorbidityLife Expectancy
AnastrozoleAromatase InhibitorsBreast Neoplasms
AffectBlood Coagulation FactorsCardiotonic Agents
See who Dr. Glaser researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Glaser works with, so you can find a warm path to the right surgical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Rebecca L. Glaser received $16 in industry payments in 2016
CMS Open Payments shows 1 general payment to Dr. Glaser from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $16.
Companies that paid Dr. Glaser the most, 2016 to 2016
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Rebecca L. Glaser's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Rebecca L. Glaser
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Rebecca L. Glaser's NPI number?
Dr. Rebecca L. Glaser's NPI number is 1184816290. It was assigned on August 13, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Rebecca L. Glaser?
Dr. Rebecca L. Glaser is a surgical oncologist in Dayton, Ohio. The primary specialty in the NPI Registry is Surgical Oncology Physician (taxonomy code 2086X0206X).
Where does Dr. Rebecca L. Glaser practice?
Dr. Glaser practices at 405 Grand Avenue, Dayton, OH 45405. Dr. Glaser's primary practice is Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare. Dmand AI also links Dr. Glaser to 1 physician office.
What is Dr. Rebecca L. Glaser's office phone number?
The practice phone on file for Dr. Glaser is (937) 723-3410.
What is Dr. Rebecca L. Glaser's medical license number?
Dr. Glaser holds Ohio license 35051389.
Which hospitals is Dr. Rebecca L. Glaser affiliated with?
Dr. Glaser practices at Kettering Health Dayton in Dayton, Ohio.
What drugs does Dr. Rebecca L. Glaser prescribe most?
In 2024 Medicare Part D data, Dr. Glaser's most prescribed drugs by claims were Hydrocortisone, Levothyroxine Sodium and Anastrozole.
Has Dr. Rebecca L. Glaser received payments from drug or device companies?
CMS Open Payments shows $16 in general payments to Dr. Glaser from 1 company from 2016 to 2016. The largest total came from Celgene Corporation.
How long has Dr. Rebecca L. Glaser been practicing?
Dr. Glaser's NPI was assigned in 2007.
Does Dr. Rebecca L. Glaser do research?
Dmand AI links 13 publications to Dr. Glaser, published from 2008 to 2020.
Who does Dr. Rebecca L. Glaser publish with?
Dr. Glaser's most frequent co-authors are Elizabeth J. Cathcart-Rake, MD (1 shared paper), Richard L. Deming, MD (1 shared paper) and Armando E. Giuliano, FACS, MD (1 shared paper).
Selling to surgical oncology practices?
See surgical oncologists in Ohio by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card